Last fall I offered testimony on behalf of simple, safe prescription rules for competitive Biologic drug substitutes. Lower-priced alternatives will benefit thousands of MI patients who depend upon these expensive medications to control their symptoms. Biologics treat diabetes, colon cancer, rheumatoid arthritis, and lung disease, among others. The FDA has thorough review and testing procedures in place for Biologic substitutes. I oppose the pharmaceutical corporations and other special interests that sought to impose higher barriers by state law.
You can view the video of my testimony here (seven minutes). My thanks to Diana Brown for willingly sharing her personal experiences for inclusion in my presentation for this MI House Health Policy Committee hearing.